I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Ted M. Dawson, M.D., Ph.D.
Director, Institute for Cell Engineering
Professor of Neurology
Expertise: Neurology, Parkinson's Disease
Research Interests: Neuronal Survival and Cell Death; Molecular and Cellular Signals Controlling Neurodegeneration
Dr. Ted Dawson focuses on movement disorders with many advances in neurobiology of disease have stemmed from Dr. Dawson's identification of the mechanisms of neuronal cell death and the elucidation of the molecular mechanisms of neurodegeneration. He pioneered the role of nitric oxide in neuronal injury in stroke and excitotoxicity and elucidated the molecular mechanisms by which nitric oxide and poly (ADP-ribose) polymerase kills neurons. His studies of nitric oxide led to major insights into the neurotransmitter functions of this gaseous messenger molecule. He co-discovered the neurotrophic properties of non-immunosuppressant immunophilin ligands. Dr. Dawson's discoveries have led to innovative approaches and enhanced the development of new agents to treat neurologic disorders, such as Parkinson's disease and Alzheimer's disease as well as other neurodegenerative disorders.
Dr. Ted Dawson received his medical degree and Ph.D. in pharmacology from the University of Utah School of Medicine. He then completed an internship in medicine at the University of Utah Affiliated Hospitals before going to the Hospital of the University of Pennsylvania for a neurology residency. Next, he came to The Johns Hopkins where he completed a fellowship in neuroscience and senior clinical fellowship in movement disorders.
- Director, Institute for Cell Engineering
- Director, Morris K. Udall Parkinson's Disease Research Center
- Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases
- Professor of Neurology
- Professor of Neuroscience
- Professor of Pharmacology and Molecular Sciences
Departments / Divisions
- M.D., University of Utah School of Medicine - Salt Lake Cty (Utah) (1986)
- Ph.D., Utah State University (Utah) (1986)
Research & Publications
The Dawson lab studies molecular mechanisms of neurodegeneration of Parkinson’s disease, nitric oxide signaling and neuronal cell death and neuroprotective and neurorestorative strategies in neurodegenerative diseases, stroke and trauma.
Parkinson’s disease is a common neurodegenerative disorder and the Dawson lab is studying the genetic basis of PD by investigating the mechanisms by which mutations in familial-linked genes cause PD, with hopes of identifying potential therapeutic targets for developing PD treatments. Current projects include the study of alpha-synuclein, LRRK2, parkin and PINK1.
Nitric oxide is a major player in neuronal cell death and the Dawson team has discovered parthanatos, a caspase-independent programmed cell death pathway involving apoptosis inducing factor (AIF) downstream of NO and its major target poly (ADP-ribose) polymerase (PARP). The team now is further characterizing that pathway to identify targets of AIF and the roles of other cell death effectors with the hope of identifying new signaling pathways that might be amenable to therapeutic intervention. NO also activates the Ras-cell survival signaling pathway and the team is characterizing novel cell survival genes targeted by this pathway.
Lab Website: Udall Center for Parkinson’s Disease Research
Selected PublicationsView all on Pubmed
Andrabi SA, Umanah GK, Chang C, Stevens DA, Karuppagounder SS, Gagné JP, Poirier GG, Dawson VL, Dawson TM. Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10209-14. doi: 10.1073/pnas.1405158111. Epub 2014 Jul 1. PMID: 24987120
Sagal J, Zhan X, Xu J, Tilghman J, Karuppagounder SS, Chen L, Dawson VL, Dawson TM, Laterra J, Ying M. Proneural transcription factor atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons. Stem Cells Transl Med. 2014 Aug;3(8):888-98. doi: 10.5966/sctm.2013-0213. Epub 2014 Jun 5. PMID: 24904172
Chen YC, Umanah GK, Dephoure N, Andrabi SA, Gygi SP, Dawson TM, Dawson VL, Rutter J. Msp1/ATAD1 maintains mitochondrial function by facilitating the degradation of mislocalized tail-anchored proteins. EMBO J. 2014 Jul 17;33(14):1548-64. doi: 10.15252/embj.201487943. Epub 2014 May 19. PMID: 24843043 [PubMed - in process]
Karuppagounder SS, Brahmachari S, Lee Y, Dawson VL, Dawson TM, Ko HS. The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease. Sci Rep. 2014 May 2;4:4874. doi: 10.1038/srep04874. PMID: 24786396 [PubMed - in process]
Chi Z, Byrne ST, Dolinko A, Harraz MM, Kim MS, Umanah G, Zhong J, Chen R, Zhang J, Xu J, Chen L, Pandey A, Dawson TM, Dawson VL. Botch is a γ-glutamyl cyclotransferase that deglycinates and antagonizes Notch. Cell Rep. 2014 May 8;7(3):681-8. doi: 10.1016/j.celrep.2014.03.048. Epub 2014 Apr 24. PMID: 24767995
Contact for Research Inquiries
Academic Affiliations & Courses
Graduate Program Affiliation
Videos & Media
Recent News Articles and Media Coverage
- Getting To The Root Of Parkinson's Disease
- Parkinson’s Disease Researchers See Hope in Leukemia Drug, Doorways to Discovery (November 2014)
- Researchers identify biological process that triggers Parkinson’s disease, FOX News (04/10/2014)
- Researchers Turn Skin Cells Into Brain Cells, A Promising Path To Better Parkinson’s Disease Treatment
- End to stem cell research challenge doesn't calm funding fears for scientists, Baltimore Sun (1/1/2013)
- What Doesn't Kill The Brain Makes It Stronger
- Johns Hopkins Team Explores Paris; Finds A Key To Parkinson's
- Parkinson's Disease: Excess of Special Protein Identified as Key to Symptoms and Possible New Target for Treatment with Widely Used Anti-Cancer Drug
- A Promising Target for Developing Treatments Against Parkinson's Disease
- Stem Cell Research: Forging Ahead